Taken together, our results suggest that the NF-κB pathway mediates upregulation of a gene expression profile associated with tumor progression in macrophages treated with JAK inhibitor and may be a mediator of macrophage derived resistance to JAK inhibition. Here, NFKB1 is linked to neoplasm.